No Data
No Data
Bausch + Lomb Brief: Ays Opal Provides a Streamlined Ordering Process for Bausch + Lomb Contact Lenses, With Select Over-the-counter Products to Be Added in the Coming Months
Express News | Blackstone, Advent International and TPG Capital Are Among a Long List of Private Equity Firms Studying Bids for Bausch + Lomb- FT
Insider Buying: CEO Brent Saunders Acquires Shares of Bausch & Lomb Corp
RBC Cuts Bausch Health Price Target to US$8.50, Maintains Sector Perform
Express News | Bausch + Lomb : Deutsche Bank Raises Target Price to $18 From $14
Bausch Health Brief: Raising Consolidated Full-year Revenue and Adjusted EBITDA (Non-GAAP) Guidance
No Data